{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:22:13Z","timestamp":1786980133784,"version":"build-2736575974"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T00:00:00Z","timestamp":1513814400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100014382","name":"Ipsen Pharma","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014382","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s00415-017-8698-2","type":"journal-article","created":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T00:31:46Z","timestamp":1513816306000},"page":"402-409","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["INTEREST IN CD2, a global patient-centred study of long-term cervical dystonia treatment with botulinum toxin"],"prefix":"10.1007","volume":"265","author":[{"name":"On behalf of the INTEREST IN CD2 study group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay P.","family":"Misra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Colosimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Charles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Mo","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Maisonobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savary","family":"Om","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,21]]},"reference":[{"issue":"Suppl 1","key":"8698_CR1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0733-8619(08)80003-5","volume":"26","author":"M Stacy","year":"2008","unstructured":"Stacy M (2008) Epidemiology, clinical presentation, and diagnosis of cervical dystonia. Neurol Clin 26(Suppl 1):23\u201342","journal-title":"Neurol Clin"},{"issue":"2","key":"8698_CR2","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/mds.870060206","volume":"6","author":"J Chan","year":"1991","unstructured":"Chan J, Brin MF, Fahn S (1991) Idiopathic cervical dystonia: clinical characteristics. Mov Disord 6(2):119\u2013126. \n                        https:\/\/doi.org\/10.1002\/mds.870060206","journal-title":"Mov Disord"},{"key":"8698_CR3","doi-asserted-by":"publisher","DOI":"10.7916\/d80c4tgj","author":"G Defazio","year":"2013","unstructured":"Defazio G, Jankovic J, Giel JL, Papapetropoulos S (2013) Descriptive epidemiology of cervical dystonia. Tremor Other Hyperkinet Mov (N Y). \n                        https:\/\/doi.org\/10.7916\/d80c4tgj","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"issue":"5","key":"8698_CR4","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1136\/jnnp.72.5.608","volume":"72","author":"Y Ben-Shlomo","year":"2002","unstructured":"Ben-Shlomo Y, Camfield L, Warner T (2002) What are the determinants of quality of life in people with cervical dystonia? J Neurol Neurosurg Psychiatry 72(5):608\u2013614","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"8698_CR5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.clineuro.2008.09.023","volume":"111","author":"T Pekmezovic","year":"2009","unstructured":"Pekmezovic T, Svetel M, Ivanovic N, Dragasevic N, Petrovic I, Tepavcevic DK, Kostic VS (2009) Quality of life in patients with focal dystonia. Clin Neurol Neurosurg 111(2):161\u2013164. \n                        https:\/\/doi.org\/10.1016\/j.clineuro.2008.09.023","journal-title":"Clin Neurol Neurosurg"},{"issue":"7","key":"8698_CR6","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1007\/s00415-002-0733-1","volume":"249","author":"J Muller","year":"2002","unstructured":"Muller J, Kemmler G, Wissel J, Schneider A, Voller B, Grossmann J, Diez J, Homann N, Wenning GK, Schnider P, Poewe W, Austrian Botulinum T, Dystonia Study G (2002) The impact of blepharospasm and cervical dystonia on health-related quality of life and depression. J Neurol 249(7):842\u2013846. \n                        https:\/\/doi.org\/10.1007\/s00415-002-0733-1","journal-title":"J Neurol"},{"key":"8698_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-014-7586-2","author":"C Comella","year":"2015","unstructured":"Comella C, Bhatia K (2015) An international survey of patients with cervical dystonia. J Neurol. \n                        https:\/\/doi.org\/10.1007\/s00415-014-7586-2","journal-title":"J Neurol"},{"issue":"1","key":"8698_CR8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1468-1331.2010.03042.x","volume":"18","author":"A Albanese","year":"2011","unstructured":"Albanese A, Asmus F, Bhatia KP, Elia AE, Elibol B, Filippini G, Gasser T, Krauss JK, Nardocci N, Newton A, Valls-Sole J (2011) EFNS guidelines on diagnosis and treatment of primary dystonias. Eur J Neurol 18(1):5\u201318. \n                        https:\/\/doi.org\/10.1111\/j.1468-1331.2010.03042.x","journal-title":"Eur J Neurol"},{"key":"8698_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.0000000000002560","volume":"86","author":"DM Simpson","year":"2016","unstructured":"Simpson DM, Hallett M, Ashman EJ (2016) Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache. Neurology 86:1\u20139","journal-title":"Neurology"},{"key":"8698_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2012-000881","author":"VP Misra","year":"2012","unstructured":"Misra VP, Ehler E, Zakine B, Maisonobe P, Simonetta-Moreau M (2012) Factors influencing response to Botulinum toxin type A in patients with idiopathic cervical dystonia: results from an international observational study. BMJ Open. \n                        https:\/\/doi.org\/10.1136\/bmjopen-2012-000881","journal-title":"BMJ Open"},{"issue":"3","key":"8698_CR11","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jval.2012.03.1385","volume":"15","author":"E Basch","year":"2012","unstructured":"Basch E (2012) Beyond the FDA PRO guidance: steps toward integrating meaningful patient-reported outcomes into regulatory trials and US drug labels. Value Health 15(3):401\u2013403. \n                        https:\/\/doi.org\/10.1016\/j.jval.2012.03.1385","journal-title":"Value Health"},{"key":"8698_CR12","doi-asserted-by":"publisher","first-page":"c2921","DOI":"10.1136\/bmj.c2921","volume":"340","author":"J Speight","year":"2010","unstructured":"Speight J, Barendse SM (2010) FDA guidance on patient reported outcomes. BMJ 340:c2921. \n                        https:\/\/doi.org\/10.1136\/bmj.c2921","journal-title":"BMJ"},{"issue":"4","key":"8698_CR13","first-page":"579","volume":"3","author":"M Weaver","year":"1997","unstructured":"Weaver M, Patrick DL, Markson LE, Martin D, Frederic I, Berger M (1997) Issues in the measurement of satisfaction with treatment. Am J Manag Care 3(4):579\u2013594","journal-title":"Am J Manag Care"},{"issue":"3","key":"8698_CR14","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1468-1331.2004.01053.x","volume":"12","author":"IM Skogseid","year":"2005","unstructured":"Skogseid IM, Kerty E (2005) The course of cervical dystonia and patient satisfaction with long-term botulinum toxin A treatment. Eur J Neurol 12(3):163\u2013170. \n                        https:\/\/doi.org\/10.1111\/j.1468-1331.2004.01053.x","journal-title":"Eur J Neurol"},{"issue":"2","key":"8698_CR15","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/imj.13167","volume":"47","author":"IA Scott","year":"2017","unstructured":"Scott IA, Attia J (2017) Cautionary tales in the interpretation of observational studies of effects of clinical interventions. Intern Med J 47(2):144\u2013157. \n                        https:\/\/doi.org\/10.1111\/imj.13167","journal-title":"Intern Med J"},{"key":"8698_CR16","unstructured":"International Society for Pharmacoepidemiology (ISPE). Guidelines for Good Pharmacoepidemiological Practices (GPP), June 2015. Accessible at: \n                        https:\/\/www.pharmacoepi.org\/resources\/guidelines_08027.cfm"},{"key":"8698_CR17","volume-title":"Therapy with botulinum toxin","author":"E Consky","year":"1994","unstructured":"Consky E, Lang AE (1994) Clinical assessments of patients with cervical dystonia. In: Jankovic J, Hallett M (eds) Therapy with botulinum toxin. Marcel Dekker, New York"},{"issue":"8501","key":"8698_CR18","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0140-6736(86)92070-2","volume":"2","author":"JK Tsui","year":"1986","unstructured":"Tsui JK, Eisen A, Stoessl AJ, Calne S, Calne DB (1986) Double-blind study of botulinum toxin in spasmodic torticollis. Lancet 2(8501):245\u2013247","journal-title":"Lancet"},{"issue":"4","key":"8698_CR19","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/mus.23409","volume":"46","author":"JS Hong","year":"2012","unstructured":"Hong JS, Sathe GG, Niyonkuru C, Munin MC (2012) Elimination of dysphagia using ultrasound guidance for botulinum toxin injections in cervical dystonia. Muscle Nerve 46(4):535\u2013539. \n                        https:\/\/doi.org\/10.1002\/mus.23409","journal-title":"Muscle Nerve"},{"key":"8698_CR20","volume-title":"Manual of botulinum toxin therapy","year":"2009","unstructured":"Truong DMD, Dressler D, Hallett M, Pathak M (eds) (2009) Manual of botulinum toxin therapy. Cambridge University Press, Cambridge"},{"issue":"3","key":"8698_CR21","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3111\/13696998.2011.653726","volume":"15","author":"KD Sethi","year":"2012","unstructured":"Sethi KD, Rodriguez R, Olayinka B (2012) Satisfaction with botulinum toxin treatment: a cross-sectional survey of patients with cervical dystonia. J Med Econ 15(3):419\u2013423. \n                        https:\/\/doi.org\/10.3111\/13696998.2011.653726","journal-title":"J Med Econ"},{"issue":"7","key":"8698_CR22","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/mds.25475","volume":"28","author":"A Albanese","year":"2013","unstructured":"Albanese A, Bhatia K, Bressman SB, Delong MR, Fahn S, Fung VS, Hallett M, Jankovic J, Jinnah HA, Klein C, Lang AE, Mink JW, Teller JK (2013) Phenomenology and classification of dystonia: a consensus update. Mov Disord 28(7):863\u2013873. \n                        https:\/\/doi.org\/10.1002\/mds.25475","journal-title":"Mov Disord"},{"issue":"10","key":"8698_CR23","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1212\/wnl.0000000000001341","volume":"84","author":"G Defazio","year":"2015","unstructured":"Defazio G, Conte A, Gigante AF, Fabbrini G, Berardelli A (2015) Is tremor in dystonia a phenotypic feature of dystonia? Neurology 84(10):1053\u20131059. \n                        https:\/\/doi.org\/10.1212\/wnl.0000000000001341","journal-title":"Neurology"},{"key":"8698_CR24","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jns.2017.02.042","volume":"376","author":"R Trosch","year":"2017","unstructured":"Trosch R, Espay A, Truong D, Gil R, Singer C, LeWitt PA, Lew MF, Tagliati M, Adler CH, Chen JJ, Marchese D (2017) Comella C (2017) Multicenter observational study of abobotulinumtoxinA neurotoxin in cervical dystonia: The ANCHOR-CD registry. J Neurol Sci 376:84\u201390. \n                        https:\/\/doi.org\/10.1016\/j.jns.2017.02.042","journal-title":"J Neurol Sci"},{"issue":"1\u20132","key":"8698_CR25","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jns.2014.12.030","volume":"349","author":"J Jankovic","year":"2015","unstructured":"Jankovic J, Adler CH, Charles D, Comella C, Stacy M, Schwartz M, Manack Adams A, Brin MF (2015) Primary results from the cervical dystonia patient registry for observation of onabotulinumtoxinA efficacy (CD PROBE). J Neurol Sci 349(1\u20132):84\u201393. \n                        https:\/\/doi.org\/10.1016\/j.jns.2014.12.030","journal-title":"J Neurol Sci"},{"key":"8698_CR26","doi-asserted-by":"publisher","first-page":"238","DOI":"10.7916\/d8mk6b1b","volume":"4","author":"HH Fernandez","year":"2014","unstructured":"Fernandez HH, Jankovic J, Holds JB, Lin D, Burns J, Verma A, Sethi K, Pappert EJ (2014) Observational Study of IncobotulinumtoxinA for Cervical Dystonia or Blepharospasm (XCiDaBLE): interim Results for the First 170 Subjects with Blepharospasm. Tremor Other Hyperkinet Mov (N Y) 4:238. \n                        https:\/\/doi.org\/10.7916\/d8mk6b1b","journal-title":"Tremor Other Hyperkinet Mov (N Y)"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-017-8698-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-017-8698-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-017-8698-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T15:15:05Z","timestamp":1589814905000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-017-8698-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,21]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["8698"],"URL":"https:\/\/doi.org\/10.1007\/s00415-017-8698-2","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,21]]}}}